Home›Antineoplastic and Immunomodulating Agents›Era (First Approved)›By Century›21st centuryBrowse By21st centuryThis dimension groups drugs by the era in which they were first approved for use. Wikipedia notes that "as a result of this complex path from discovery to commercialization, partnering has become a standard practice for advancing drug candidates through development pipelines," pipelines that end in an approval dated to a specific era. Browsing by era lets a visitor compare drugs first approved in the same period.Facts21st centurySourcesComments (0)Reader Challenges (0)FactsComparisonATC Level 1 CodeWell-attestedSourced to the subject's own accountL - Antineoplastic and immunomodulating agents 121st centuryFilter Results45 entriesATC ClassAllL: Antineoplastic and Immunomodulating Agents (44)S: Sensory Organs (1)Route of AdministrationAllIntratumoral (2)Intravenous (18)Intravesical (1)Oral (19)Subcutaneous (5)Approval StatusAllApproved (41)Investigational / Clinical Trial (2)Withdrawn (2)WHO Essential MedicineAllComplementary List (3)Treats (Condition)AllArthritis (1)COVID-19 (1)Giant cell arteritis (1)Graft-Versus-Host Disease (1)Hidradenitis Suppurativa (1)Psoriasis (1)Severe Acute Respiratory Syndrome (1)Uveitis (1)Show ResultsBrowseCompareSelect all 45Abraxane21st centuryActemra21st centuryAdalimumab21st centuryAllogeneic processed thymus tissue21st centuryAllogeneic umbilical cord-derived CD34- cells, non-expanded/dorocubicel21st centuryAmivantamab/hyaluronidase21st centuryAxicabtagene ciloleucel21st centuryBevacizumab21st centuryBinimetinib21st centuryBrexucabtagene autoleucel21st centuryBrigatinib21st centuryCobimetinib21st centuryDecitabine/cedazuridine21st centuryEncorafenib21st centuryFedratinib21st centuryFruquintinib21st centuryIdecabtagene vicleucel21st centuryImatinib21st centuryLifileucel21st centuryLisocabtagene maraleucel21st centuryMelphalan flufenamide21st centuryMotixafortide21st centuryNadofaragene firadenovec21st centuryNiraparib/abiraterone acetate21st centuryOmidubicel21st centuryPanobinostat21st centuryRadotinib21st centuryRemestemcel21st centuryRexin G21st centuryRipretinib21st centuryRucaparib21st centurySacituzumab govitecan21st centurySugemalimab21st centuryTabelecleucel21st centuryTagraxofusp21st centuryTazemetostat21st centuryTeserpaturev21st centuryTislelizumab21st centuryTivozanib21st centuryTocilizumab21st centuryTrametinib21st centuryTucatinib21st centuryUmbralisib21st centuryVorasidenib21st centuryVusolimogene oderparepvec21st centurySources1. Anatomical Therapeutic Chemical Classification System (Wikipedia)tier 3WikipediaATC Level 1 codes table, group LQuote, ATC Level 1 codes table, group LL - "Antineoplastic and immunomodulating agents"View the SourceComments (0)No comments yet. Be the first to share a thought.Sign in to join the discussion.Reader Challenges (0)No disputes yet. Spotted an error or a better source? Open the first one.Sign in to dispute this or suggest a correction.